Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianyuan Zeng

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomolecules|August 6, 2021
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in CancersJianyuan Zeng, Wen G Jiang, Andrew J Sanders
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Endoscopic colorectal polyp detection based on improved YOLOv8Jincai Huang, Jianyuan Zeng, Jinfeng Peng, et al.
International Journal of Molecular Sciences|December 11, 2022
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug ResistanceJianyuan Zeng, Andrew J Sanders, Lin Ye, et al.
In Vivo (Athens, Greece)|April 27, 2023
Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients' Treatment ResponsesZiqian Fang, Jimmy Jianyuan Zeng, Yiming Yang, et al.
Food Research International (Ottawa, Ont.)|December 3, 2017
Effect of in vitro simulated gastrointestinal digestion on polyphenol and polysaccharide content and their biological activities among 22 fruit juicesMinjing He, Jianyuan Zeng, Lu Zhai, et al.
Biomolecules|April 30, 2021
EPLIN Expression in Gastric Cancer and Impact on Prognosis and ChemoresistanceWenjing Gong, Jianyuan Zeng, Jiafu Ji, et al.
Scientific Reports|December 27, 2024
EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancerJianyuan Zeng, Cai Wang, Fiona Ruge, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 11, 2023
Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatmentAmber Xinyu Li, Jimmy Jianyuan Zeng, Tracey A Martin, et al.
Cancer Genomics & Proteomics|December 27, 2023
Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug ResistanceAmber Xinyu Li, Jimmy Jianyuan Zeng, Elyas Khan, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomolecules|August 6, 2021
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in CancersJianyuan Zeng, Wen G Jiang, Andrew J Sanders
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Endoscopic colorectal polyp detection based on improved YOLOv8Jincai Huang, Jianyuan Zeng, Jinfeng Peng, et al.
International Journal of Molecular Sciences|December 11, 2022
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug ResistanceJianyuan Zeng, Andrew J Sanders, Lin Ye, et al.
In Vivo (Athens, Greece)|April 27, 2023
Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients' Treatment ResponsesZiqian Fang, Jimmy Jianyuan Zeng, Yiming Yang, et al.
Food Research International (Ottawa, Ont.)|December 3, 2017
Effect of in vitro simulated gastrointestinal digestion on polyphenol and polysaccharide content and their biological activities among 22 fruit juicesMinjing He, Jianyuan Zeng, Lu Zhai, et al.
Biomolecules|April 30, 2021
EPLIN Expression in Gastric Cancer and Impact on Prognosis and ChemoresistanceWenjing Gong, Jianyuan Zeng, Jiafu Ji, et al.
Scientific Reports|December 27, 2024
EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancerJianyuan Zeng, Cai Wang, Fiona Ruge, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 11, 2023
Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatmentAmber Xinyu Li, Jimmy Jianyuan Zeng, Tracey A Martin, et al.
Cancer Genomics & Proteomics|December 27, 2023
Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug ResistanceAmber Xinyu Li, Jimmy Jianyuan Zeng, Elyas Khan, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
Pageof 1